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ABSTRACT 
Employment of recombinant viruses as gene transfer vectors is limited by constraints on the size and functional 
design of the genetic material to be transferred as well as potential safety hazards deriving from obligatory 
co-transfer of viral genetic elements. As an alternative strategy that capitalizes on the efficient cellular entry 
mechanisms of viruses, we have derived adenovirus-polylysine-DNA complexes whereby foreign DNA is 
transferred bound to the exterior of the virion. This linkage was accomplished utilizing an antibody bridge in 
which a monoclonal antibody was rendered competent to carry DNA by the attachment of a polylysine residue. 
Attachment of the antibody-polylysine to the virus was by virtue of the antibody's specificity for the virion. 
The resulting vector system mediates high-efficiency gene transfer to target cells in vitro. In addition, this 
vector design allows greatly enhanced flexibility in terms of the size and design of heterologous sequences that 
can be transferred. Since this strategy selectively exploits viral entry functions, which are independent of viral 
gene expression, the potential exists to derive vectors that avoid the hazards deriving from transfer of parent 
virus genome. 
O V E R V I E W SUMMARY 
Gene transfer is being applied to more and more clinical 
problems. Not unexpectedly, ingenious new ways are being 
found to improve gene transfer efficiency. Curiel et al. have 
developed a clever system where they attach the DNA of 
interest to the outside of a virion, rather than putting it 
inside. 
INTRODUCTION 
R ECOMBINANT VIRAL GENE TRANSFER VECTORS accomplish gene transfer by capitalizing on the efficient entry mecha-
nisms of their parent viruses. This strategy has been employed 
in the design of recombinant retroviral and adenoviral vectors to 
achieve high-efficiency gene transfer in vitro and in vivo 
(Berkner, 1988; Eglitis and Anderson, 1988). Despite their 
efficacy, these agents possess limitations related to the size and 
construction of the heterologous DNA to be transferred. In 
addition, these agents pose safety hazards deriving from the 
co-transfer of viable genetic elements of the parent virus. 
To circumvent these limitations, alternative strategies have 
been developed to accomplish gene delivery by exploiting cel-
lular mechanisms of macromolecular transport. For example, 
the highly efficient receptor-mediated endocytosis pathway has 
been exploited to achieve gene transfer (Wu and Wu, 1987; 
Wagner et aL, 1990). This approach utilizes bifunctional mo-
lecular conjugates that possess a domain to bind DNA and a 
separate domain with specificity for a cell-surface receptor (Wu 
andWu, 1987; Wagner et aL, 1990; Cotten etaL, 1991). When 
the ligand domain is recognized by the appropriate cell-surface 
receptor, the conjugate is internalized by the receptor-mediated 
endocytosis pathway, co-transporting the bound DNA. Gene 
transfer efficiencies equal to or greater than other DNA-medi-
ated techniques have been accomplished by this route (Zenke 
etaL, 1990; Cotten etaL, 1991). 
Although this vector system can achieve high levels of DNA 
delivery to cells possessing the appropriate cell-surface recep-
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tor, corresponding gene expression is often idiosyncratic (Cot­
ten et aL, 1990, 1991). It has been suggested that the basis for 
this observation is that DNA delivered by the receptor-mediated 
endocytosis pathway is targeted for lysosomal degradation 
(Cotten et aL, 1990, 1991; Zenke et aL, 1990). Thus, the fact 
that the endosome-internalized DNA lacks a specific mecha­
nism to escape from the intracellular vesicle system represents 
an intrinsic limitation of conjugate-mediated gene delivery. Re­
cently, we have observed that gene transfer by transferrin-
polylysine conjugates is greatly augmented by infection with 
adenovirus (Curiel et aL, 1991). This effect was achieved by 
capitalizing on the fact that adenoviruses enter cells via the 
receptor-mediated endocytosis pathway and possess a specific 
mechanism to escape the vesicle system of the cell by mediating 
disruption of the endosomes, thus allowing entry of the trans-
ferrin-polylysine DNA complexes into the cytoplasm (Pastan 
et aL, 1986). On the basis of these findings, we have con­
structed a conjugate system that possesses the capacity to medi­
ate endosome disruption by incorporating the adenovirus into 
its functional design. The adenovirus-polylysine-DNA com­
plexes mediate highly efficient gene transfer in vitro and, by 
virtue of their design, allow enhanced flexibility in terms of 
genetic material to be transferred compared to conventional 
recombinant viral gene transfer vectors. 
M A T E R I A L S AND METHODS 
Preparation of components of adenovirus— 
poly lysine comp I exes 
To accomplish linkage between adenovirus and a polycation 
DNA-binding moiety without functional disruption of the cap-
sid proteins, an antibody bridge was employed whereby a poly-
lysine moiety was conjugated to a monoclonal antibody with 
specificity for the adenoviral capsid (Fig. 1). Since the adenovi­
ral fiber and penton proteins are important in mediating viral 
attachment and entry while the major capsid protein, hexon, 
appears less important in these processes (Seth et aL, 1984), 
antibody attachment was via the hexon protein. This specific 
attachment was achieved utilizing a chimeric adenovirus (P202-
Ad5) that has a foreign epitope in the surface region of its hexon 
protein in conjunction with a monoclonal antibody specific for 
the heterologous epitope (MP301). Control experiments dem­
onstrated that attachment of the monoclonal antibody MP301 
was nonneutralizing for adenovirus P202-Ad5. To prepare 
the antibody-polylysine, monoclonal antibody MP301 (20.6 
nmoles) in 1 ml of 200 mM HEPES pH 7.9 was treated with a 5 
ιιιΛί ethanolic solution of /V-succinimidyl 3-(2-pyridyldithio)-
propionate (SPDP) (100 nmoles). After 3 hr at 22°C, purifica-
adenovirus 
70-80 nm 
F I G . 1. Schematic of approach to derive adenovirus-polylysine-DNA complexes containing heterologous DNA attached to 
exterior of adenovirus capsid. To accomplish linkage of an adenovirus and a polycationic DNA-binding domain, the chimeric 
adenovirus P202-Ad5 containing a heterologous epitope in the exterior domain of its hexon protein was employed in conjunction 
with the monoclonal antibody MP301 specific for this epitope. The monoclonal antibody was rendered competent to carry foreign 
DNA sequences by attaching a polylysine moiety. Interaction of the polylysine-antibody complexed DNA with adenovirus 
P202-Ad5 occurs via the specificity of the conjugated antibody. 
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tion was performed by a Sephadex G25 gel filtration to give 19 
nmoles of MP301 modified with 62 nmoles of dithiopyridine 
linker. The modified antibody was reacted with 3-mercaptopro-
pionate-modified poly(L-lysine) (22 nmoles, with an average 
chain length of 300 lysine residues, FITC-labeled, and modi­
fied with 56 nmoles of mercaptoproprionate-linker) in 100 mM 
HEPES buffer pH 7.9 under argon atmosphere. Conjugates 
were isolated by cation-exchange chromatography on a Mono S 
HR 5/5 column (Pharmacia) using a gradient from 20% A to 
100% Β (A, 50 mM HEPES pH 7.9; B, A + 3 Μ NaCl). The 
main product fraction, eluting between 1.65 Μ and 2 Μ salt, 
was pooled and dialyzed against HBS (20 mM HEPES pH 7.3, 
150 mM NaCl) to yield MP301 (9.1 nmoles) conjugated to 9.8 
nmoles of polylysine. To derive adenovirus P202-Ad5, site-
directed mutagenesis was performed on the adenovirus 5 hexon 
gene to replace amino acids 188-194 with 15 amino acids from 
the Mycoplasma pneumoniae PI protein (Inamine et α!., 1988). 
This insertion is in loop 11 of the hexon protein, which is 
located on the outer surface of the virion (Roberts et αι., 1986). 
These 15 amino acids contain the epitope for the monoclonal 
antibody MP301. The details of this work will be described 
elsewhere. 
Preparation of adenovirus-polylysine-DNA complexes 
Complexation of the DNA to the polylysine monoclonal anti­
body was accomplished by diluting 6 μg of DNA to a 350 μΐ 
total volume in HBS and combining with 9.5 μg MP301-poly­
lysine conjugate in 150 μΐ total volume of the same buffer. The 
DNA plasmid pRSVL containing the Photinus pyralis lu-
ciferase gene under the control of the Rous sarcoma virus long 
terminal repeat enhancer/promoter was used as a reporter gene 
(De Wet et a!., 1987). The reaction mixture was incubated 30 
min at room temperature. This amount of polylysine-antibody 
was calculated to be the amount necessary to achieve electro-
neutrality of the input DNA. The polylysine-antibody-com-
plexed DNA was diluted in HBS to achieve a final concentra­
tion of 5 x 10'° DNA molecules per milliliter. Adenovirus 
P202-Ad5 was diluted in ice-cold Dulbecco modified Eagle 
medium (DMEM) supplemented with 2% fetal calf serum 
(FCS) to achieve a concentration of 5 x 10 1 0 viral particles per 
milliliter. Equal volumes of the polylysine-antibody-DNA and 
virus were combined and incubated for 30 min at room temper­
ature. The HeLa target cells for the gene transfer experiments 
were maintained in DMEM supplemented with 5% FCS, peni­
cillin at 100 international units (IU)/ml, and streptomycin 100 
μg/ml in 60-mm tissue culture plates. For comparison to HeLa 
cells, the cell lines HBE1, KB, and MRC-5 were evaluated. 
HBE1, a respiratory epithelial cell line, was grown in F12-7X 
medium as described (Willumsen etaL, 1989). KB and MRC-5 
were grown in Eagle minimal essential medium, 10% heat-
inactivated (h.i.) FCS, penicillin at 100 lU/ml, streptomycin at 
100 μg/ml, 10 mM nonessential amino acids, and 2 mM glu-
tamine. Prior to application of the reaction mixture, the plates 
were cooled by incubation at 4°C for 30 min. After this incuba­
tion, the media was removed from the tissue culture dishes and 
1 ml of complex applied. The treated cells were incubated at 
4°C for 2 hr. This step allowed binding of formed complexes 
without cellular internalization. After this binding step, plates 
were washed three times with ice-cold 2% FCS/DMEM to 
remove unbound reaction components in the fluid phase. The 
plates were then gradually warmed up after the addition of 2 ml 
ice-cold 2% FCS/DMEM and returned to the incubator (37°C, 
5% C0 2 ) for 16 hr. To evaluate reporter gene expression, cell 
lysates were prepared, standardized for total protein content, 
and analyzed for luciferase activity as previously described 
(Wagner et al,. 1990). Aliquots of cell lysate containing 50 μg 
of total cellular protein were analyzed. The luminometer had 
been calibrated such that 1 pg of luciferase produced 50,000 
light units. Reporter plasmid DNA pRSVL was combined with 
adenovirus P202-Ad5 (DNA + P202-Ad5) and pRSVL DNA 
complexed to the polylysine monoclonal antibody was employed 
in the absence of the specific virus (DNA + MP301pLys) for 
comparison to the complete combination of the complex com­
ponents (DNA + MP301pLys + P202-Ad5). The identical 
complex reaction was evaluated utilizing specific adenovirus 
that had been heat inactivated (45°C, 30 min) prior to complex 
formation (DNA + MP301pLys + P202-Ad5[h.i.]). Competi­
tion experiments were performed by incubating the specific 
adenovirus in the presence of the polylysine monoclonal anti­
body MP301pLys plus a 10-fold molar excess of nonlysinated 
monoclonal antibody MP301 (DNA + MP301pLys + 
MP301 + P202-Ad5) or polylysine monoclonal antibody 
MP301pLys and a 10-fold molar excess of nonlysinated ir­
relevant, monoclonal antibody, anti-rat IgG (DNA 4-
MP301pLys + anti-rat IgG + P202-Ad5). DNA was also com­
plexed with nonconjugated polylysine (4 μg) in amounts equi-
molar to polylysine-antibody prior to incubation with the spe­
cific virus (DNA + pLys + P202-Ad5). Complex formation 
reactions containing adenovirus WT300, which lacks the heter­
ologous epitope recognized by MP301, were exactly as for the 
specific virus P202-Ad5 (DNA + MP301pLys + WT300). To 
determine the optimum ratio of complex components, various 
molar ratios of complex components were evaluated for the 
capacity to mediate gene transfer to HeLa cells. Complex for­
mation reactions were as before except that 2.5 x 10'° poly-
lysine-anlibody-complexed DNA molecules were used for each 
reaction in combination with variable amounts of the specific 
adenovirus P202-Ad5. Application of complexes to cells and 
analysis of reporter gene expression was exactly as before. To 
determine gene transfer efficiency mediated by adenovirus-
polylysine-DNA complexes, limiting dilutions of the complex 
were evaluated for the capacity to mediate detectable levels of 
reporter gene expression in HeLa cells. After formation, loga­
rithmic dilutions of the complex were performed in 2% FCS/ 
DMEM. One-milliliter aliquots of the various dilutions of com­
plex were applied to 60-mm tissue culture dishes containing 
5 x 105 HeLa cells. After 1 hr incubation (37°C, 5% C 0 2 ) , 3 
ml of 5% FCS/DMEM was added and the plates were incubated 
for an additional 16 hr as before. Determination of reporter gene 
expression was as before. Experiments were performed in trip­
licate and data depicted represents the mean ± SEM. 
Preparation of chimeric complexes containing 
adenovirus and human transferrin 
To prepare ternary complexes containing a combination of 
adenovirus and human transferrin domains, the epitope-tagged 
adenovirus P202-Ad5 (2.5 x 10 1 0 particles) was diluted in 750 
μΐ of 2% FCS/DMEM and combined with polylysine mono-
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clonal antibody MP301pLys (2 μg) diluted in 250 μΐ of HBS. 
Incubation was performed for 30 min at room temperature. 
Plasmid DNA pRSVL (6 ^g) diluted in 250 μΐ of HBS was then 
added to the mixture and incubated for an additional 30 min at 
room temperature. The resulting adenovirus-polylysine-DNA 
complexes were predicted to possess incompletely condensed 
DNA based upon total polylysine content. To complete DNA 
condensation and contribute a human transferrin moiety to the 
complexes, human transferrin polylysine conjugates (Wagner 
et aL, 1990) (9 μg) diluted in 250 μΐ of HBS were added to the 
adenovirus-polylysine-DNA complexes. A final incubation of 
30 min at room temperature was performed. The resulting chi­
meric complexes were incubated with tissue culture cells to 
achieve specific binding of the formed complexes (4°C, 2 hr). 
The plates were then washed three times with ice-cold 2% 
FCS/DMEM and returned to the incubator (37°C, 5% C 0 2 ) for 
16 hr after the addition of 2 ml of 2% FCS/DMEM. Evaluation 
of reporter gene expression was as before. 
R E S U L T S 
Gene transfer mediated by adenovirus-polylysine-
DNA complexes 
To evaluate the capacity of the adenovirus-polylysine-DNA 
complexes to mediate gene transfer, a plasmid encoding the 
firefly luciferase gene was used as a reporter (De Wet et aL, 
1987). The epithelial cell line HeLa was used as a target for the 
complexes because these cells possess a defined population of 
cell-surface receptors for adenoviruses (Philipson et aL, 1968). 
When employed in combination, the components of this conju­
gate system mediated high levels of expression of the luciferase 
reporter gene (Fig. 2). Control experiments demonstrated that 
the adenovirus did not significantly augment target cell delivery 
of uncomplexed plasmid DNA. Reporter DNA complexed by 
the polylysine monoclonal antibody was also not appreciably 
transferred to the target HeLa cells. In marked contrast, when 
the monoclonal antibody-bound DNA was allowed to interact 
with the epitope-tagged adenovirus, the resulting complex me­
diated high-level gene expression. This effect was abolished by 
heat treatment of the virions prior to complex formation. Since 
heat treatment selectively abrogates adenoviral entry functions 
without perturbing viral structural integrity (Defer et aL, 1990), 
it is apparent that the specific internalization functions of the 
adenovirus comprise a significant component of the gene trans­
fer capacity of the complexes. Competition for the heterologous 
epitope on the surface of the chimeric adenovirus by nonlysi-
nated specific monoclonal antibody also attenuated the net gene 
expression accomplished by the complex. This effect was not 
seen with an irrelevant monoclonal antibody. Thus, the specific 
interaction between the monoclonal antibody-bound DNA and 
the corresponding adenoviral surface epitope is important in 
permitting functional gene delivery by the complex. Consistent 
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F I G . 2. Gene transfer mediated by adenovirus-polylysine-DNA complexes. Various combinations of specific and nonspecific 
complex components were evaluated for the capacity to mediate reporter gene transfer to HeLa cells. Reporter plasmid pRSVL (6 
μg) [DNA) was complexed with either antibody-polylysine (9.5 μg) |MP30lpLys] or equimolar amounts of unconjugated 
polylysine (4 μg) [pLys]. The complexed DNA was diluted prior to combination with adenovirus. Epitope-tagged virus [P202-
Ad5] or irrelevant adenovirus [WT300] (2.5 x 10'° particles) was added to the DNA complexes (2.5 x 10 1 0 DNA molecules) in 
the absence or presence of nonlysinated monoclonal antibody [MP301] or equimolar amounts of irrelevant monoclonal antibody 
[anti-rat IgG]. For some experiments adenovirus P202 was heat inactivated [P202-Ad5(h.i.)J prior to combination with antibody-
polylysine-DNA complexes. After incubation, cell lysates were evaluated for luciferase reporter gene expression. 
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with this concept, an adenovirus lacking the epitope recognized 
by the polylysine antibody was not capable of mediating the 
high levels of gene expression achieved by the virus that pos­
sessed this epitope. Further, polylysine-complexed DNA was 
not appreciably transferred to target cells by the adenovirus, 
indicating that the gene transfer capacity of the complexes was 
not on the basis of DNA condensation but contingent upon the 
antibody-mediated attachment of the reporter gene to the virion. 
Interaction of plasmid DNA with polylysine conjugates re­
sults in significant structural alterations of the DNA molecule, 
characterized most prominently by marked condensation into a 
80- to 100-nm diameter toroid structure (Wagner et al.t 1991). 
The diameter of the adenovirus is also on the order of 70-80 nm 
(Philipson, 1983). When evaluated experimentally, it was 
shown that adenovirus input in molar excess of polylysine-
antibody-complexed DNA yielded a plateau of reporter gene 
expression at a ratio of unity (Fig. 3). Thus, the optimized 
conjugate consists of a single adenoviral cognate domain in 
association with a single polylysine-antibody DNA-binding do­
main. 
We next examined the efficiency of gene transfer of the 
adenovirus-polylysine conjugates at this optimized ratio. Log­
arithmic dilutions of the complex administered to target cells 
yielded a corresponding logarithmic decrease in reporter gene 
expression (Fig. 4). Significantly, 5 x I 0 6 DNA molecules 
delivered by this vector system to 5 x 105 HeLa cells produced 
detectable levels of reporter gene expression. Thus, administra­
tion of as few as 10 DNA molecules per cell in the form of 
adenovirus-polylysine-DNA complexes accomplished detect­
able foreign gene expression. This is in marked contrast to the 
amount of input DNA required by DNA-mediated gene transfer 
vectors, where on the order of 500,000 DNA molecules per cell 
are required (Feigner etaL, 1987, 1989; Maurer, 1989). 
In the configuration of the adenovirus-polylysine-DNA 
complexes, the adenovirus moiety functions both in the capac­
ity of an endosomc disruption agent and as the ligand domain of 
the complex. Thus, the gene transfer efficiency of the com­
plexes for a given target cell should reflect the relative number 
of adenoviral cell surface receptors. Both HeLa and KB, cell 
1:8 1:4 1:2 1:1 2:1 4:1 8:1 
Ratio P202-Ad5:MP301pLys/DNA 
F I G . 3. Determination of optimum ratio of complex compo­
nents to mediate gene transfer. A fixed amount of antibody-
poly lysine-DN A complex was combined with various molar 
ratios of epitope-tagged adenovirus and evaluated for the capac­
ity to mediate gene transfer to HeLa cells. 
lines known to possess high levels of adenoviral receptors (Phil­
ipson et al., 1968), demonstrated a corresponding high degree 
of susceptibility to gene transfer via adenoviral-polylysine-
DNA complexes (Fig. 5). In contrast, the relatively low number 
of adenoviral receptors characterizing MRC-5 (Precious and 
Russell, 1985) and HBEl (data not shown) is reflected in a 
lower level of gene transfer to these cell lines mediated by the 
complexes. 
Gene transfer mediated by chimeric complexes 
containing human transferrin and adenovirus domains 
Specific internalization of molecular conjugate gene transfer 
vectors is dictated by the tropism of the conjugate ligand do-
105 I II I I I I I I I 
10'° 108 107 
DNA Molecules 
F I G . 4. Determination of gene transfer efficiency mediated 
by adenovirus-polylysine-DNA complexes. Limiting dilutions 
of the complex were evaluated for the capacity to mediate 
detectable levels of luciferase gene expression in HeLa cells. 
Dotted line indicates background levels of luciferase gene ex­
pression in untreated HeLa cells. 
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F I G . 5. Gene transfer to various cell lines mediated by ade­
novirus-polylysine-DNA complexes. Epitope-tagged adenovi­
rus P202-Ad5 (2.5 x I 0 l ( ) particles) was added to complexes 
formed between antibody-polylysine MP30lpLys and reporter 
plasmid DNA pRSVL. The resulting adenovirus-polylysine-
DNA complexes were incubated with the cell lines HeLa, 
HBEl . KB, and MRC-5 as for Fig. 2. Reporter gene expression 
in the cell lysates was evaluated as before. 
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F I G . 6. Gene transfer mediated by chimeric complexes containing adenovirus and human transferrin. A. Relative levels of gene 
expression mediated by human transferrin-polylysine-DNA complexes, adenovirus-polylysine-DNA complexes, and ternary 
complexes containing a combination of adenovirus and human transferrin domains. Transferrin-polylysine-DNA complexes were 
formed by combination of pRSVL DNA (6 μg) with human transferrin-polylysine conjugate (12 μg) as described (Wagner et aL, 
1990) [hTfpLJ. Adenovirus-polylysine-DNA complexes [AdpL] were prepared as in Fig. 2. Chimeric complexes were formed by 
sequential addition of polylysine monoclonal antibody MP301pLys (2 μg), plasmid DNA pRSVL (6 μg), and human transferrin-
polylysine (9 μg) to the epitope-tagged adenovirus P202-Ad5 (2.5 x 10'° particles) [AdpL/hTfpLJ. Delivery to HeLa cells and 
evaluation of reporter gene expression was as before. B. Relative susceptibility to gene transfer by adenovirus-human transferrin 
ternary complexes. Chimeric complexes containing a combination of adenovirus and human transferrin domains were formed as 
above. Delivery to the cell lines HeLa and HBEl and analysis of reporter gene expression was as for Fig. 2. 
main for receptors on the cell surface. Subsequent to internal­
ization, gene transfer efficiency is limited by the conjugate's 
lack of a specific mechanism to escape entrapment within the 
cell vesicle system. Adenovirus-polylysine-DNA complexes 
exploit adenoviral-mediated endosome disruption to enhance 
gene transfer efficiency. In this specific configuration, how­
ever, the adenoviral domain also functions as the ligand moiety 
of the conjugate, limiting the efficacy of this vector to target 
cells containing surface receptors for adenovirus. As an alterna­
tive means to exploit the endosome disruption capacity of the 
adenovirus, ternary complexes were constructed that contained 
an alternate cell-surface ligand moiety in conjunction with an 
adenovirus moiety. In this arrangement, it was hypothesized 
that the adenovirus moiety would mediate endosome disruption 
after internalization via the adenoviral pathway or the pathway 
of the alternate ligand. To evaluate this concept, ternary com­
plexes were constructed that contained a human transferrin 
ligand domain in conjunction with an adenoviral domain. The 
gene transfer efficiency of these chimeric complexes was com­
pared to human transferrin-polylysine-DNA complexes (Wag­
ner et aL, 1990) and adenovirus-polylysine-DNA complexes 
in HeLa cells, a cell line containing cell-surface receptors for 
both adenovirus and transferrin (Huebers and Finch, 1987). The 
ternary complexes accomplished significantly greater levels of 
reporter gene expression than the conjugates that possessed 
exclusively transferrin or adenovirus ligand domains (Fig. 6A). 
The magnitude of this augmentation was clearly not on the basis 
of an additive effect of human transferrin-polylysine-DNA 
complexes plus adenovirus-polylysine-DNA complexes. Since 
the ternary complexes may be internalized via the adenoviral or 
transferrin pathways, this apparent cooperativity suggests that 
the adenovirus domain facilitates entry via either pathway, 
likely on the basis of adenovirus-mediated endosomolysis. 
To demonstrate the selective employment of the endosome 
disruption capacity of the adenoviral domain of the ternary 
complex, the chimeric complexes were delivered to cell lines 
that exhibited variable susceptibility to adenovirus-polylysine-
DNA complexes (Fig. 6B). The respiratory epithelial cell line 
HBEl shows very low levels of gene transfer mediated by 
adenovirus-polylysine-DNA complexes, compared to HeLa 
cells (Fig. 5), reflecting the relatively low cell surface popula­
tion of adenoviral receptors characterizing this line. In marked 
contrast, employment of the adenovirus-transferrin ternary 
complexes resulted in levels of gene expression comparable to 
those seen in HeLa cells. The susceptibility of this cell line to 
gene transfer via the ternary complexes is consistent with the 
concept that the adenoviral domain is internalized via the trans­
ferrin pathway, where it augments gene transfer by mediating 
endosome disruption. Thus, it appears feasible to exploit selec­
tively the endosomolysis property of adenovirus in the design of 
molecular conjugate vectors that thereby possess the capacity to 
escape the cell vesicle system. 
DISCUSSION 
The design of molecular conjugate gene transfer vectors cap­
italizes on the receptor-mediated endocytosis pathway to ac­
complish DNA delivery (Cotten et aL, 1991). Despite the effi­
cient cellular internalization, however, DNA delivered by this 
route is largely trapped within the cell vesicle system, due to the 
fact that conjugate vectors lack a specific mechanism to facili-
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täte DNA escape from the endosome (Cotten et al., 1990). This 
concept led us to explore the utility of employing the adenovirus 
as an endosome disruption agent in conjunction with molecular 
conjugate-mediated gene delivery. In this regard, it was found 
that adenoviral-mediated endosomolysis dramatically aug-
mented the gene transfer efficiency of transferrin-polylysine 
conjugates (Curiel et al., 1991). Because molecular conjugate 
gene transfer vectors are limited by their lack of a specific 
mechanism to accomplish escape from the cell vesicle system, 
and because the adenovirus possesses such a mechanism, it was 
logical to incorporate the adenovirus into the functional design 
of the conjugate. Thus, the adenovirus-polylysine-DNA conju-
gates circumvent the principal limitation inherent in described 
molecular conjugate systems in possessing a specific mecha-
nism to accomplish escape from the cell vesicle system. 
The coupling of DNA to the exterior of the virion represents a 
radical conceptual departure from recombinant viral vectors 
utilized heretofore. Important advantages derive from this de-
sign whereby the foreign DNA to be transferred is not inte-
grated into the genome of the parent virus, as is the standard 
design of recombinant viral vectors (Berkner, 1988; Eglitis and 
Anderson, 1988). These advantages include a much greater 
flexibility in the functional design of the foreign gene sequences 
expressed, as transcription is not dependent on promoters in the 
parent virus genome. In addition, this strategy allows a greatly 
increased size of foreign DNA that can be transferred, because 
the packaging constraints of the virus do not limit the amount of 
DNA that can be carried on the exterior. Over and above these 
practical and immediate advantages, important potential safety 
features derive from the design of the vector. Conventional 
recombinant viral vectors mediate obligatory co-delivery of 
genome elements of the parent virus, from which potential 
safety hazards derive (Anderson, 1984; Ledley, 1989). Because 
the adenovirus-polylysine complexes selectively exploit viral 
entry features, the viral genome is not an essential feature. This 
design allows the possibility of modifying the present system 
with a functionally and/or structurally inactivated viral genome 
to minimize the safety hazards deriving from the transfer of 
viable genes from the parent virus. 
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